This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of heart, mediastinum and pleura
C3_HEART_MEDIASTINUM_PLEURA
Heart neoplasm: Tumors in any part of the heart. They include primary cardiac tumors and metastatic tumors to the heart. Their interference with normal cardiac functions can cause a wide variety of symptoms including HEART FAILURE; CARDIAC ARRHYTHMIAS; or EMBOLISM.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
574 |
4. Check minimum number of eventsNone |
574 |
5. Include endpointsNone |
574 |
6. Filter based on genotype QC (FinnGen only) |
510 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of heart, mediastinum and pleura
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of heart, mediastinum and pleura, including Hilmo
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 510 | 145 | 365 |
| Unadjusted period prevalence (%) | 0.13 | 0.05 | 0.17 |
| Median age at first event (years) | 70.05 | 63.64 | 72.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 526
- Matched controls
- 5260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
310.1
266
*
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
307.7
320
*
H02AB02
ATC
dexamethasone; systemic
201.5
307.7
235
21
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
73.2
307.7
274
77
A04AA01
ATC
ondansetron; systemic, rectal
61.8
293.2
169
40
A03FA01
ATC
metoclopramide; systemic, rectal
20.0
274.9
291
307
Z51.5
ICD-10 Finland
Palliative care
25.0
241.4
193
119
N02AA05
ATC
oxycodone; systemic
13.0
202.6
301
490
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
47.2
190.8
115
31
J94.8
ICD-10 Finland
Other specified pleural conditions
41.3
182.4
114
35
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
24.0
181.8
141
79
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
168.0
152
*
JN4BD
NOMESCO Finland
Extensive body CT
18.2
166.6
150
113
TGA30
NOMESCO Finland
Thoracocentesis
84.6
137.0
73
10
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
132.0
121
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
26.3
127.8
92
42
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
122.8
113
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
697.2
116.8
111
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
38.9
104.1
65
19
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
300.2
99.4
98
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.3
99.3
160
264
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.0
91.7
101
102
JN4AD
NOMESCO Finland
Body CT examination
9.0
89.3
127
180
GD1AD
NOMESCO Finland
Thorax CT examination
9.6
84.5
111
142
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
41.5
80.1
49
13
UGC12
NOMESCO Finland
Flexible bronchoscopy
8.1
79.4
122
188
A04AA02
ATC
granisetron; systemic, transdermal
445.5
79.1
77
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
17.3
78.2
67
44
WF049
NOMESCO Finland
Radiotherapy of metastasis
737.5
67.5
65
*
L03AA02
ATC
filgrastim; parenteral
685.9
63.2
61
*
L03AA13
ATC
pegfilgrastim; parenteral
353.4
62.8
62
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
62.8
59
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
346.7
61.7
61
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
60.6
57
*
GAC00
NOMESCO Finland
Biopsy of pleura
175.3
60.3
62
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
13.7
59.9
58
47
ZX120
NOMESCO Finland
Intravenous
7.0
56.3
96
163
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
212.6
56.2
57
*
L01CA04
ATC
vinorelbine; systemic
+∞
54.1
51
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
54.1
51
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
22.7
53.7
40
19
XX3DW
NOMESCO Finland
Time consuming IT work
8.1
48.6
70
98
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
19.1
48.5
39
22
WW500
NOMESCO Finland
Blood transfusion
11.9
45.7
48
44
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
171.6
45.6
47
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
45.1
352
1855
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
44.4
42
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
41.9
209
824
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
41.8
182
657
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
+∞
41.2
39
*
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
40.1
38
*
N02AA01
ATC
morphine; systemic, rectal
13.1
39.7
39
32
WZC30
NOMESCO Finland
Teaching
4.3
39.6
121
339
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.8
39.4
44
44
C61
ICD-10 Finland
Malignant neoplasm of prostate
216.0
39.4
40
*
WF002
NOMESCO Finland
Radical radiotherapy
147.9
39.3
41
*
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
39.0
37
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
38.0
36
*
1BA04, ,
NOMESCO Finland
+∞
38.0
36
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
35.8
34
*
J94.9
ICD-10 Finland
Pleural condition, unspecified
42.4
34.9
43
11
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
359.3
34.3
34
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
128.5
34.1
36
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
32.6
31
*
R84
ICPC
Malignant neoplasm bronchus/lung
343.5
32.2
32
*
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
120.9
32.1
34
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
31.6
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
30.5
29
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
30.5
29
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
319.9
30.1
30
*
GAA31
NOMESCO Finland
Thoracoscopy
164.4
30.0
31
*
JN4CD
NOMESCO Finland
Very extensive body CT
11.3
29.8
32
30
A06AH03
ATC
naloxegol; oral
53.4
29.7
35
7
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.4
27
*
J01MA14
ATC
moxifloxacin; systemic
3.9
26.8
89
261
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
26.7
62
138
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
26.5
111
380
TPX10
NOMESCO Finland
Implantation of vascular injection port
9.9
26.4
31
33
9679/3-C38.3
ICD-O-3
Mediastinal large B-cell lymphoma of mediastinum, NOS
+∞
26.3
25
*
A79
ICPC
Malignancy NOS
+∞
26.3
25
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
26.3
25
*
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.3
26.2
46
79
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
142.0
25.9
27
*
B03BA03
ATC
hydroxocobalamin; parenteral
4.3
25.5
72
187
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.2
24
*
TK800
NOMESCO Finland
Hemodialysis
8.0
24.5
34
45
116
Kela drug reimbursment
Prostate cancer
+∞
24.1
23
*
J01MA12
ATC
levofloxacin; systemic
2.9
23.9
144
607
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
23.8
155
680
H02AB06
ATC
prednisolone; systemic
2.5
23.4
294
1767
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
23.1
22
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
23.1
22
*
8000/3-C38.4
ICD-O-3
Neoplasm, malignant of pleura, NOS
+∞
22.0
21
*
A04AD12
ATC
aprepitant; systemic
+∞
22.0
21
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
83.8
21.9
24
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
21.7
222
1205
R06.0
ICD-10 Finland
Dyspnoea
2.5
21.5
207
1091
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.8
21.2
27
32
9663/3-C38.3
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of mediastinum, NOS
+∞
21.0
20
*
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
16.7
20.8
33
21
D70.82
ICD-10 Finland
Drug-induced neutropenia
114.6
20.7
22
*
JN6AD
NOMESCO Finland
CT of torso and neck
26.8
20.6
28
11
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
43.6
20.6
25
6
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
19.9
19
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
19.2
148
698
L02AE02
ATC
leuprorelin; implant, parenteral
57.2
19.1
22
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
19.0
65
193
9680/3-C38.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of mediastinum, NOS
+∞
18.9
18
*
R85
ICPC
Malignant neopl respiratory other
+∞
17.8
17
*
WX600
NOMESCO Finland
Single shot through catheter
19.5
17.5
26
14
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.8
16
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
16.8
16
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
16.8
16
*
B01AB10
ATC
tinzaparin; parenteral
3.4
16.7
65
210
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
175.3
16.6
17
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.1
16.1
19
*
N03AX16
ATC
[U] pregabalin
2.4
15.9
132
638
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.7
15
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
15.7
15
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
15.7
15
*
R82
ICPC
Pleurisy/pleural effusion
87.8
15.6
17
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
87.8
15.6
17
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
164.7
15.6
16
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
39.3
15.5
19
5
R4110
NOMESCO Finland
Physiotherapy
2.3
15.4
159
844
Z2446
NOMESCO Finland
Social worker
3.7
15.1
50
145
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
14.6
14
*
C45
ICD-10 Finland
Mesothelioma
+∞
14.6
14
*
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
82.5
14.6
16
*
J86.9
ICD-10 Finland
Pyothorax without fistula
13.1
14.5
25
20
XW000
NOMESCO Finland
Bone marrow biopsy
5.1
14.4
31
64
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
13.6
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.6
13
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
13.6
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
GAC43
NOMESCO Finland
Total decortication of pleura
143.6
13.5
14
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
13.5
23
38
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.5
13.3
47
142
B01AB05
ATC
enoxaparin; parenteral
2.1
13.3
170
974
A02BC02
ATC
pantoprazole; systemic
2.0
12.6
347
2584
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
12.5
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
12.2
77
325
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.8
12.0
22
39
WW200, ,
SPAT
0.3
11.8
45
1140
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
11.7
83
370
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
66.5
11.7
13
*
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
23.5
11.6
16
7
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
115
Kela drug reimbursment
Breast cancer
+∞
11.5
11
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
11.5
11
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
11.5
11
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
11.5
11
*
C38.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
122.6
11.5
12
*
GEA00
NOMESCO Finland
Mediastinoscopy
35.9
11.3
14
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
35.9
11.3
14
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
25.7
11.2
15
6
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
11.1
187
1167
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
11.0
115
605
SPAT1109
SPAT
Analgesia with portable analgesic pump
28.7
10.8
14
5
R50.9
ICD-10 Finland
Fever, unspecified
2.3
10.6
91
440
Z2221
NOMESCO Finland
Medical doctor
2.0
10.6
140
802
HA1AA
NOMESCO Finland
X-ray mammography
5.6
10.5
20
37
Y77
ICPC
Malignant neoplasm prostate
112.2
10.5
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
112.2
10.5
11
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.4
10
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
10.4
10
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
12.4
10.4
18
15
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
33.2
10.4
13
*
ZXE00
NOMESCO Finland
One hour or less
1.9
10.4
197
1274
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
10.4
28
70
ZX112
NOMESCO Finland
Subcutaneous
19.2
10.3
15
8
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
10.3
197
1276
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
10.0
42
142
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.4
9.9
21
26
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
5.3
9.9
20
39
N02AX02
ATC
tramadol; systemic, rectal
1.8
9.8
224
1529
WX402
NOMESCO Finland
General anaesthesia
2.1
9.6
98
508
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
101.8
9.4
10
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
101.8
9.4
10
*
1XC02, ,
NOMESCO Finland
30.6
9.4
12
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
8.3
9.4
20
25
N05CF01
ATC
zopiclone; oral
1.8
9.4
181
1168
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
9.4
9
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
9.4
9
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
9.4
9
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
9.4
9
*
L01CB01
ATC
etoposide; systemic
+∞
9.4
9
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
9.4
9
*
R4190
NOMESCO Finland
Nutritional therapy
4.8
9.4
21
45
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
9.2
87
437
WW200
NOMESCO Finland
Immunization
4.3
9.0
23
55
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.0
8.9
19
39
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
50.9
8.7
10
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
50.9
8.7
10
*
R93.8
ICD-10 Finland
Abnormal findings on diagnostic imaging of other specified body structures
50.9
8.7
10
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
8.6
71
337
GAC46
NOMESCO Finland
Partial decortication of pleura
91.5
8.4
9
*
D38.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thymus
91.5
8.4
9
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
C38.0
ICD-10 Finland
Malignant neoplasm: Heart
+∞
8.4
8
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
8.4
8
*
8000/3-C38.3
ICD-O-3
Neoplasm, malignant of mediastinum, NOS
+∞
8.4
8
*
Z31.6
ICD-10 Finland
General counselling and advice on procreation
14.8
8.2
13
9
J93.9
ICD-10 Finland
Pneumothorax, unspecified
17.5
8.1
12
7
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
15.3
7.7
12
8
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
25.4
7.6
10
*
N06DX01
ATC
memantine; oral
0.2
7.5
9
385
TGC00
NOMESCO Finland
Bronchial lavation
4.0
7.5
21
54
NK6AN
NOMESCO Finland
Total body bone isotope imaging
81.2
7.4
8
*
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
81.2
7.4
8
*
GDC00
NOMESCO Finland
Lobectomy of lung
81.2
7.4
8
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
81.2
7.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
7.3
7
*
C38.2
ICD-10 Finland
Malignant neoplasm: Posterior mediastinum
+∞
7.3
7
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
7.3
7
*
159
Kela drug reimbursment
Pazopanib
+∞
7.3
7
*
Z3231
NOMESCO Finland
Registered nurse
1.8
7.1
134
848
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
7.1
6
319
WZC30, ,
SPAT
0.2
7.1
5
298
B01AB04
ATC
dalteparin; parenteral
3.1
7.0
29
97
P20
ICPC
Memory disturbance
0.4
7.0
28
715
J93.8
ICD-10 Finland
Other pneumothorax
14.0
6.9
11
8
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.7
6.8
35
133
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.3
6.8
25
78
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
40.6
6.8
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
6.7
101
1586
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.0
6.7
17
29
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
10.2
6.6
12
12
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.3
6.5
24
75
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
6.5
27
91
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
6.5
234
1752
WPA16, ,
SPAT
70.7
6.4
7
*
J01FF01
ATC
clindamycin; systemic
1.7
6.4
130
839
XX2RW, ,
NOMESCO Finland
11.2
6.3
11
10
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.9
6.3
18
47
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
6.3
6
*
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
+∞
6.3
6
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
6.3
6
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
GEC23
NOMESCO Finland
Transsternal thymectomy
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
WPA43, ,
SPAT
+∞
6.3
6
*
9680/3-C38.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pleura, NOS
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
+∞
6.3
6
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
6.3
6
*
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
27.0
6.2
8
*
C10AA07
ATC
rosuvastatin; oral
0.5
6.2
71
1212
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
3.8
6.1
18
48
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
6.0
31
118
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
194
69
43.96
302.69
1.9
1.3
40.34
27.50
g/l
10.32
185
61
171
59
42.46
267.86
2.0
1.3
1783.56
2155.95
e6/l
0.29
135
40
162
50
46.37
261.88
2.0
1.3
40547.39
187209.74
e6/l
0.55
114
27
133
48
36.75
203.38
1.7
1.4
4.60
6.66
mmol/l
4.34
128
43
139
90
20.63
166.99
2.2
1.4
—
—
—
0
0
171
163
15.06
165.49
2.3
3.1
—
—
—
0
0
155
212
9.95
113.63
2.2
1.4
3.99
2.80
ug/l
0.57
123
153
84
110
8.90
62.11
1.6
1.5
—
—
—
0
0
202
643
4.48
57.91
5.5
2.7
0.78
0.83
mmol/l
9.71
192
596
370
2165
3.39
36.87
19.2
6.0
4.78
4.46
e9/l
1.08
328
1848
37
42
9.40
30.15
1.2
1.0
—
—
—
0
0
315
1821
2.82
29.39
7.1
4.1
31.44
35.25
g/l
18.89
304
1690
53
99
5.84
27.71
1.3
1.7
—
—
—
0
0
30
30
10.54
26.72
1.9
1.6
40.94
24.49
ng/l
0.36
30
30
337
2139
2.60
24.14
10.9
19.3
1.15
1.38
inr
16.95
274
1801
32
42
8.05
23.18
1.3
1.3
—
—
—
0
0
38
61
6.64
23.04
1.6
1.3
—
—
—
0
0
333
2137
2.52
22.73
10.0
6.7
1.21
1.21
mmol/l
0.05
300
1832
175
854
2.57
21.44
6.0
2.1
2.51
2.44
mmol/l
11.99
161
746
305
1919
2.40
21.18
9.7
6.5
1.20
1.20
mmol/l
0.04
298
1737
189
970
2.48
20.67
3.1
2.3
—
—
—
0
0
41
82
5.34
19.83
1.6
1.3
8.94
7.30
u/l
0.39
34
69
235
1349
2.34
19.78
7.7
2.1
2.36
2.35
mmol/l
0.49
220
1172
44
100
4.71
18.36
1.8
1.3
—
—
—
0
0
42
100
4.48
16.54
1.7
1.3
—
—
—
0
0
159
830
2.31
16.10
2.3
1.9
—
—
—
0
0
27
47
6.00
15.07
1.3
1.3
—
—
—
0
0
23
15
15.97
14.52
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
50
155
3.46
13.65
3.6
3.0
0.31
0.36
iu/ml
0.43
28
83
75
299
2.76
13.30
4.3
4.7
2.74
2.01
mmol/l
1.05
68
223
24
47
5.30
11.84
1.4
1.2
—
—
—
0
0
150
853
2.06
11.73
2.1
1.7
1.85
1.46
mg/l
0.79
120
672
264
1831
1.89
11.44
3.5
2.6
—
—
estimate
—
0
0
34
95
3.76
10.81
1.5
1.2
—
—
—
0
0
385
3053
1.97
10.68
17.2
5.5
85.90
78.32
u/l
3.19
380
2841
302
3753
0.54
10.40
5.2
7.4
39.50
40.35
mmol/mol
0.92
266
3479
51
190
2.87
10.22
5.1
5.7
26.04
24.90
mmol/l
1.66
51
172
118
643
2.08
10.20
2.1
1.8
—
—
—
0
0
92
1644
0.47
10.15
1.5
1.9
1.35
1.30
mmol/l
0.29
75
1359
332
2546
1.82
9.78
9.1
5.4
6.58
6.85
mmol/l
2.29
325
2421
45
161
2.96
9.70
1.4
2.2
31.87
38.74
u/l
1.57
40
134
191
1250
1.83
9.50
4.3
2.6
29.57
36.29
u/l
1.64
184
1181
98
1679
0.49
9.39
2.5
3.5
7.94
7.72
mmol/l
0.19
82
1427
109
601
2.03
9.05
1.9
1.8
—
—
—
0
0
108
594
2.03
9.02
9.9
8.2
1.51
1.00
mmol/l
0.73
96
485
66
302
2.36
8.72
1.7
1.5
—
—
—
0
0
29
85
3.55
8.62
1.5
1.2
—
—
—
0
0
16
16
10.27
8.58
2.6
3.9
—
—
—
0
0
105
587
1.99
8.34
6.3
5.6
1.05
1.04
mmol/l
0.16
97
530
318
3820
0.58
8.29
3.9
5.3
1.41
1.39
mmol/l
0.26
276
3481
25
68
3.81
8.27
1.4
1.2
—
—
—
0
0
101
1651
0.52
8.05
3.3
4.2
3.05
8.82
mg/mmol
3.67
52
1081
323
3853
0.58
7.99
3.9
5.4
4.38
4.32
mmol/l
0.50
282
3541
149
946
1.80
7.96
5.3
4.2
153.96
361.69
ng/l
1.49
128
799
27
81
3.46
7.76
1.7
1.2
—
—
—
0
0
24
67
3.71
7.66
1.9
1.4
24.95
20.83
iu/l
0.20
19
60
182
1236
1.72
7.65
2.8
3.0
0.66
0.38
e6/l
0.70
137
904
333
3928
0.59
7.65
4.2
6.3
2.56
2.49
mmol/l
0.88
283
3600
54
241
2.38
7.54
1.6
1.6
—
—
—
0
0
18
41
4.51
7.48
2.0
1.3
—
—
—
0
0
51
1029
0.44
7.37
3.5
4.1
1.02
1.02
kg/l
0.19
35
664
65
318
2.19
7.32
1.8
1.6
—
—
—
0
0
19
35
5.59
6.98
1.1
1.3
—
—
—
0
0
18
32
5.79
6.81
1.4
1.2
—
—
—
0
0
18
45
4.11
6.67
2.4
4.0
—
—
—
0
0
18
35
5.29
6.37
4.7
2.9
63.19
56.21
%
0.64
18
28
9
5
18.28
6.28
1.9
6.6
1.21
1.92
ratio
—
9
5
18
36
5.14
6.23
2.0
1.4
—
—
—
0
0
22
68
3.33
6.07
2.5
1.9
151.20
9333.50
u/l
—
8
18
11
11
10.18
6.05
2.9
1.9
3.14
4.76
nmol/l
0.43
11
11
10
9
11.30
5.81
3.2
1.1
186.78
—
pmol/l
—
5
0
12
16
7.65
5.66
2.7
1.7
0.41
0.88
e9/l
1.68
12
16
311
3644
0.64
5.64
3.5
4.6
1.20
1.25
mmol/l
0.82
265
3285
212
1590
1.56
5.60
2.7
3.1
—
—
—
0
0
176
1274
1.57
5.39
4.2
2.4
53.00
60.40
u/l
1.07
168
1175
194
1447
1.54
5.16
2.9
3.1
18.97
136.30
e6/l
1.70
147
1108
210
1603
1.52
4.98
3.4
3.4
1004.31
1793.07
ng/l
4.92
196
1409
63
352
1.90
4.95
2.5
2.1
33.29
34.40
u/l
0.09
56
285
39
183
2.22
4.89
2.4
1.7
—
—
—
0
0
114
761
1.64
4.83
2.0
2.6
9.64
12.50
umol/l
5.46
109
704
100
646
1.68
4.81
11.3
7.0
103.40
104.66
mmol/l
1.99
100
646
152
1099
1.54
4.57
4.0
2.6
301.57
365.26
umol/l
8.75
138
942
13
27
4.91
4.52
1.5
1.1
—
—
—
0
0
31
138
2.32
4.40
1.3
1.3
1.13
1.12
g/l
0.04
31
133
344
3878
0.67
4.29
4.7
5.6
6.05
6.11
mmol/l
0.30
302
3518
26
109
2.46
4.21
4.9
3.6
1.47
1.53
index
0.02
19
61
120
1646
0.65
4.16
3.4
3.8
0.00
0.01
estimate
0.50
39
369
165
2116
0.68
4.05
1.8
2.2
97.05
94.03
pmol/l
0.31
102
1135
13
31
4.27
4.03
2.4
1.2
—
—
—
0
0
13
31
4.27
4.03
2.4
1.2
—
—
—
0
0
13
31
4.27
4.03
2.4
1.2
—
—
—
0
0
105
718
1.58
3.99
2.8
2.9
2.80
1.77
e6/l
0.46
50
361
8
11
7.37
3.87
2.4
1.1
—
—
—
0
0
8
11
7.37
3.87
2.4
1.1
—
—
—
0
0
8
11
7.37
3.87
2.4
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
19
5.34
3.84
1.0
1.2
—
—
—
0
0
35
174
2.08
3.84
2.1
1.6
—
—
—
0
0
10
20
5.07
3.70
1.6
1.2
—
—
—
0
0
29
136
2.20
3.68
1.2
1.3
—
—
—
0
0
11
25
4.47
3.64
1.6
1.2
—
—
—
0
0
10
22
4.61
3.44
1.6
1.2
—
—
—
0
0
14
47
3.03
3.43
2.5
1.4
89.43
90.66
%
0.42
14
47
9
18
5.07
3.38
6.8
2.6
0.44
1.11
index
—
9
18
328
3677
0.71
3.37
6.6
4.8
2.09
1.99
mu/l
0.41
298
3326
25
115
2.23
3.34
1.7
2.1
119.25
131.43
g/l
0.91
16
92
6
9
6.73
2.87
3.0
1.2
62.00
78.44
nmol/l
—
6
9
141
1776
0.72
2.84
4.2
4.2
21.16
24.52
%
2.09
72
899
181
2190
0.74
2.81
3.4
3.8
36.36
0.00
estimate
0.49
44
454
8
18
4.50
2.80
2.4
1.1
—
—
—
0
0
8
18
4.50
2.80
2.4
1.1
—
—
—
0
0
8
18
4.50
2.80
2.4
1.1
—
—
—
0
0
8
18
4.50
2.80
2.4
1.1
—
—
—
0
0
143
1793
0.72
2.79
2.2
2.4
78.44
77.76
nmol/l
0.10
125
1565
183
2205
0.74
2.74
3.3
3.9
0.00
0.02
estimate
0.79
42
429
6
10
6.05
2.70
2.5
1.7
1.58
1.30
%
—
6
10
8
19
4.26
2.68
1.9
4.5
—
—
—
0
0
180
2158
0.75
2.55
3.4
3.8
0.00
0.00
estimate
-0.00
43
441
113
1449
0.72
2.48
1.5
1.8
22.78
19.45
nmol/l
1.51
104
1214
183
2182
0.75
2.47
5.3
4.5
2.53
2.12
ug/l
0.92
153
1954
8
22
3.68
2.37
1.0
1.2
—
—
—
0
0
51
336
1.57
2.30
1.2
1.5
—
—
—
0
0
10
34
2.98
2.29
1.1
1.1
2.05
6.79
nmol/l
—
5
6
8
23
3.52
2.27
1.0
1.2
—
—
—
0
0
6
13
4.65
2.27
1.2
1.5
—
—
—
0
0
6
13
4.65
2.27
1.2
1.5
—
—
—
0
0
96
1248
0.72
2.27
3.5
3.9
0.00
0.00
estimate
-0.00
39
400
5
9
5.60
2.22
1.2
1.2
—
—
—
0
0
10
36
2.81
2.14
1.3
1.4
—
—
—
0
0
101
775
1.38
2.11
2.8
2.8
1.57
1.19
e6/l
0.30
46
421
10
37
2.73
2.08
1.3
1.4
—
—
—
0
0
10
37
2.73
2.08
1.3
1.4
—
—
—
0
0
5
10
5.04
2.07
1.0
1.1
—
—
—
0
0
77
1021
0.71
2.03
1.6
1.8
516.68
413.84
pmol/l
1.69
59
832
19
97
1.99
2.02
1.7
1.3
—
—
—
0
0
19
97
1.99
2.02
1.7
1.3
—
—
—
0
0
126
1007
1.33
2.02
2.2
2.4
4.29
4.33
e6/l
0.02
116
908
8
26
3.11
2.02
1.1
1.2
68.38
51.12
u/l
—
8
21
22
119
1.89
2.00
1.7
1.6
0.02
0.11
iu/ml
—
9
24
10
39
2.59
1.95
1.3
1.3
—
—
—
0
0
10
39
2.59
1.95
1.3
1.3
—
—
—
0
0
402
4266
0.76
1.95
51.3
24.1
124.82
135.59
g/l
31.32
397
4203
402
4264
0.76
1.92
50.5
23.9
4.28
4.48
e12/l
10.58
391
4148
402
4264
0.76
1.92
52.4
24.5
38.15
40.30
%
14.83
396
4203
402
4262
0.76
1.89
50.4
23.8
90.25
91.62
fl
7.21
396
4202
402
4262
0.76
1.89
50.5
23.9
283.29
235.65
e9/l
19.44
391
4165
18
94
1.95
1.82
1.8
1.3
4.24
4.01
mmol/l
0.23
18
89
17
88
1.96
1.76
1.4
1.2
—
—
—
0
0
6
18
3.36
1.75
1.2
1.5
—
—
—
0
0
6
18
3.36
1.75
1.2
1.5
—
—
—
0
0
329
3007
1.25
1.71
5.1
4.2
22.98
12.22
mm/h
10.75
320
2759
6
19
3.18
1.66
1.3
3.6
874.17
614.37
u/ml
—
6
19
5
14
3.59
1.62
1.0
1.4
—
—
—
0
0
6
21
2.88
1.51
1.2
1.0
—
—
—
0
0
0
45
0.00
1.50
0.0
1.0
—
48.46
—
0
29
0
45
0.00
1.50
0.0
1.0
—
596.19
—
0
31
274
3000
0.82
1.48
5.7
3.7
15.17
14.98
pmol/l
0.62
255
2688
9
39
2.33
1.43
1.3
1.3
—
—
—
0
0
19
111
1.74
1.41
1.9
1.3
582.74
520.50
mg/l
0.21
19
105
9
41
2.22
1.37
3.7
2.4
—
—
—
0
0
5
17
2.96
1.36
6.4
1.1
41.32
37.30
g/l
—
5
17
8
35
2.31
1.27
1.3
1.3
—
—
—
0
0
9
45
2.02
1.24
1.1
1.4
—
—
—
0
0
18
108
1.69
1.24
1.4
1.6
—
—
—
0
0
5
19
2.65
1.22
1.0
1.3
—
—
—
0
0
26
380
0.67
1.20
2.8
2.4
0.23
0.36
e6/l
0.72
26
358
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
8
40
2.02
1.12
1.0
1.1
—
—
—
0
0
10
51
1.98
1.12
1.0
1.2
2.40
4.88
u/ml
—
5
24
10
51
1.98
1.12
4.0
2.6
1.13
0.44
mmol/l
—
10
51
80
653
1.27
1.11
1.4
1.3
23.32
35.18
iu/ml
0.77
19
196
402
4196
0.82
1.10
42.1
21.3
79.31
85.48
umol/l
2.96
396
4136
18
112
1.63
1.10
1.0
1.1
—
—
—
0
0
5
21
2.39
1.09
1.8
7.2
—
40.17
—
0
6
6
125
0.47
1.05
1.8
1.8
36.67
44.90
nmol/l
—
6
116
17
106
1.62
1.04
9.6
2.9
1.15
1.82
mg/l
3.57
17
93
18
114
1.60
1.04
1.0
1.1
—
—
—
0
0
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
58
461
1.29
1.01
2.3
2.7
7.80
7.55
ug/l
0.05
48
402
395
4118
0.84
0.99
21.3
10.3
24.43
25.34
u/l
0.54
388
3959
96
1125
0.82
0.98
3.1
3.3
0.00
0.00
estimate
0.50
37
343
12
69
1.76
0.97
1.6
1.2
—
—
—
0
0
43
552
0.76
0.96
7.8
7.2
—
—
—
0
0
16
102
1.59
0.91
1.1
1.3
—
—
—
0
0
8
43
1.87
0.87
1.0
1.1
—
—
—
0
0
6
31
1.95
0.84
1.2
1.1
168.00
94.81
pmol/l
—
6
31
73
612
1.22
0.83
1.3
1.3
26.46
11.94
u/ml
0.39
16
211
16
106
1.53
0.79
1.1
1.4
—
—
—
0
0
198
1814
1.15
0.79
4.7
4.4
32.80
89.44
ng/l
1.33
166
1411
23
165
1.41
0.79
1.4
1.6
3.12
8.71
iu/ml
—
6
44
54
441
1.25
0.78
2.0
3.4
175.98
256.07
ng/l
1.37
46
411
24
325
0.73
0.78
6.7
2.2
77.30
60.29
ml/min/173m2
—
10
131
15
99
1.53
0.76
2.1
1.3
41.11
82.43
e6/l
—
9
82
15
99
1.53
0.76
2.1
1.4
32.33
1372.21
e6/l
—
9
84
397
4110
0.86
0.75
37.9
20.6
4.01
4.02
mmol/l
0.33
391
4017
54
444
1.24
0.75
4.7
3.1
—
—
—
0
0
26
193
1.37
0.74
1.2
1.2
58.22
106.04
u/ml
—
8
80
30
228
1.33
0.74
3.7
6.1
1.69
1.66
%
0.07
30
220
397
4108
0.86
0.73
37.6
20.6
138.52
139.78
mmol/l
13.40
391
4020
5
25
2.01
0.73
1.0
3.0
—
—
—
0
0
23
168
1.39
0.72
1.0
1.2
—
—
—
0
0
221
2059
1.13
0.67
3.0
2.7
—
—
—
0
0
62
525
1.21
0.66
1.4
1.5
—
—
—
0
0
29
224
1.31
0.66
1.1
1.7
2.05
1.51
g/l
1.43
24
197
26
337
0.76
0.66
2.5
4.2
99.83
103.27
ng/l
0.05
18
293
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
70
805
0.85
0.61
1.3
1.3
1.22
1.33
u/ml
—
9
208
8
52
1.55
0.59
1.1
1.3
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
79
893
0.86
0.56
1.6
1.8
1101.69
1147.73
nmol/l
0.13
51
679
15
108
1.40
0.53
1.2
1.2
—
2.35
—
0
13
24
303
0.78
0.52
2.0
2.3
—
—
—
0
0
13
93
1.41
0.48
1.2
1.2
—
1.00
—
0
5
13
177
0.73
0.48
2.2
1.8
2.96
3.40
mmol/l
—
7
140
7
47
1.50
0.47
1.9
1.2
—
—
—
0
0
133
1235
1.10
0.42
2.0
2.3
3.37
2.88
mg/l
1.31
115
1053
14
105
1.34
0.41
1.4
1.2
—
—
—
0
0
14
105
1.34
0.41
1.5
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
3.5
—
10.10
—
0
15
0
15
0.00
0.41
0.0
3.5
—
4.99
—
0
15
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
61
542
1.14
0.40
5.8
3.6
6.12
5.82
kpa
0.97
61
528
252
2415
1.08
0.39
4.8
3.1
56.24
49.74
u/l
0.52
242
2235
16
124
1.30
0.39
2.6
1.4
5.23
1.42
ratio
—
10
79
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
400
3921
1.08
0.32
39.5
15.9
44.06
26.87
mg/l
12.61
386
3196
23
271
0.84
0.30
2.0
2.2
—
—
—
0
0
8
107
0.74
0.29
1.7
1.6
—
—
—
0
0
28
323
0.86
0.29
1.2
1.4
—
—
—
0
0
19
162
1.18
0.23
1.4
2.1
—
—
—
0
0
5
39
1.28
0.23
1.4
1.2
—
104.00
—
0
5
367
3731
0.95
0.21
32.9
15.4
81.32
75.39
ml/min/173m2
6.27
347
3455
0
11
0.00
0.21
0.0
9.3
—
11.03
—
0
11
0
10
0.00
0.21
0.0
1.3
—
13.94
—
0
5
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
7
63
1.11
0.17
2.3
1.8
—
—
—
0
0
8
69
1.16
0.16
1.0
1.1
20.84
22.34
u/l
—
8
59
6
78
0.77
0.15
1.0
1.2
1.48
1.51
g/l
—
6
78
9
83
1.09
0.14
1.1
1.1
—
142.67
—
0
6
24
264
0.90
0.14
4.3
3.3
25.86
24.98
mmol/l
0.99
24
256
118
1220
0.96
0.13
3.3
3.1
0.89
0.78
ug/l
0.62
86
860
35
326
1.08
0.12
2.3
2.2
0.18
0.19
g/l
0.91
35
297
22
239
0.92
0.10
2.0
2.0
2.94
3.43
ratio
1.93
17
199
28
293
0.95
0.05
6.9
4.0
47.40
48.40
%
0.06
28
286
22
232
0.95
0.05
1.5
1.2
222.60
267.80
u/ml
0.14
22
217
182
1833
0.99
0.02
2.8
3.0
336.33
136.46
ug/l
3.13
172
1689
16
152
1.05
0.02
1.1
1.0
—
—
—
0
0
12
127
0.94
0.01
1.0
1.3
—
—
—
0
0
54
533
1.01
0.01
4.2
5.3
34.11
32.36
%
0.46
36
344
45
456
0.99
0.00
7.1
3.2
4.90
4.45
kpa
0.47
45
442
13
135
0.96
0.00
1.5
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.8
—
7.59
—
0
8
5
50
1.00
-0.00
1.4
2.6
10.80
11.16
mmol/l
—
5
50
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
8
82
0.98
-0.00
1.1
1.2
0.95
0.92
g/l
—
8
82
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
21.43
—
0
6
0
6
0.00
-0.00
0.0
8.8
—
5.07
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_HEART_MEDIASTINUM_PLEURA – Malignant neoplasm of heart, mediastinum and pleura
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).